Radiotherapy clinical trials at UCSF
1 research study open to eligible people
Radiotherapy involves using radiation to target and kill cancer cells. At UCSF, researchers are investigating a new treatment that uses radiotherapy along with an experimental drug for advanced cancers. Another study is looking at combining radiotherapy with immune therapy to see its effects.
Showing trials for
NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy
open to eligible people ages 18 years and up
The 1100 study is an open-label, Phase I, dose escalation and expansion prospective clinical study to assess the safety of intratumoral injection of NBTXR3 activated by radiotherapy in combination with anti-PD-1 therapy.
San Francisco, California and other locations
Our lead scientists for Radiotherapy research studies include Jason Chan.
Last updated: